Osimertinib in epidermal growth factor receptor (EGFR) T790M advanced non-small cell lung cancer (NSCLC): Analysis of patients with central nervous system (CNS) metastases in a real-world study (ASTRIS)

Giulio Metro, Mariano Provencio, D.-w. Kim, Byoung Chul Cho, K. Park, Yuxi Pan, Yu Shi, R. Migliorino, Marcello Tiseo, Jia Yu, Qiang Zhou, Antonio Santo, Andrea Ardizzoni, Y. Hu, Yi‐Long Wu, S.-w. Kim, Michele Miranda, A. Fernandes, Filippo de MarinisAnnals 2019 · DOI

BibTeX
@article{metro2019osimertinib,
  author = {Giulio Metro and Mariano Provencio and D.-W. Kim and Byoung Chul Cho and K. Park and Yuxi Pan and Yu Shi and R. Migliorino and Marcello Tiseo and Jia Yu and Qiang Zhou and Antonio Santo and Andrea Ardizzoni and Y. Hu and Yi‐Long Wu and S.-W. Kim and Michele Miranda and A. Fernandes and Filippo de Marinis},
  title = {{Osimertinib in epidermal growth factor receptor (EGFR) T790M advanced non-small cell lung cancer (NSCLC): Analysis of patients with central nervous system (CNS) metastases in a real-world study (ASTRIS)}},
  journal = {Annals},
  year = {2019},
  doi = {10.1093/annonc/mdz260.043},
}

Loading related content...

Figure